Related Experiment Videos
Umbilical cord blood transplants
1Department of Hematology and Bone Marrow Transplant, Hospital Saint Louis, Paris, France. eliane.gluckman@sls.ap-hop-paris.fr
Current Opinion in Hematology
|October 31, 2000
Summary
Umbilical cord blood transplants show results comparable to bone marrow transplants. Cord blood reduces graft-versus-host disease but may delay engraftment, confirming its potential for hematopoietic stem cell allogeneic transplants.
Area of Science:
- Hematology
- Transplant Immunology
- Oncology
Background:
- Cord blood banking is expanding globally, increasing the availability of hematopoietic stem cells.
- Umbilical cord blood (UCB) transplants are increasingly utilized for both related and unrelated recipients.
- UCB transplantation offers an alternative to bone marrow transplantation.
Purpose of the Study:
- To compare the outcomes of UCB hematopoietic stem cell transplantation with bone marrow transplantation.
- To evaluate the incidence of complications, graft-versus-host disease, and relapse rates in UCB transplant recipients.
- To confirm the benefits of UCB hematopoietic stem cells in allogeneic transplantation.
Main Methods:
- Analysis of available data comparing UCB transplants with related and unrelated bone marrow transplants.
- Evaluation of engraftment times, transplant complications, and graft-versus-host disease (GVHD) incidence.
- Assessment of relapse rates in leukemia patients undergoing UCB transplantation.
Main Results:
- UCB transplants demonstrate overall results comparable to bone marrow transplants.
- Delayed engraftment and increased early transplant complications were observed with UCB.
- Significantly reduced incidence of acute and chronic graft-versus-host disease (GVHD) was noted with UCB grafts, even in HLA-mismatched cases.
- Relapse rates in leukemia patients were similar to those in bone marrow transplant recipients.
Conclusions:
- Umbilical cord blood hematopoietic stem cells are a viable option for allogeneic transplantation.
- UCB transplantation offers a reduced risk of GVHD, making it advantageous in certain patient populations.
- Despite delayed engraftment, UCB transplantation presents significant potential benefits for patients requiring hematopoietic stem cell transplants.